595223 Discloses an immunogenic composition comprising a meningococcal lipooligosaccaride (LOS) and a pneumococcal serotype 14 capsular saccharide (CS 14, CS14), wherein the LOS and/or CS 14 do(es) not include Galbeta-4GlcNAcbeta1-3Galbeta1-4Glc (LNnT) tetrasaccharide.